The potential effects of new synthetic drugs against Leishmania amazonensis and Trypanosoma cruzi

Microbios

Volumn 90, Issue 362, 1997, Pages 51-60

  Canto Cavalheiro, M M ^a   Echevarria, A ^b   Araujo, C A C ^a   Bravo, M F ^a   Santos, L H S ^b   Jansen, A M ^a   Leon, L L ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL RURAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Chaga disease; Chemotherapy; Ieishmaniasis; Synthetic drugs

Indexed keywords

ANTIPROTOZOAL AGENT; ANTITRYPANOSOMAL AGENT; BENZAMIDINE DERIVATIVE;

ANIMAL; ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECT; DRUG SCREENING; GROWTH, DEVELOPMENT AND AGING; LEISHMANIA MEXICANA; MOUSE; STRUCTURE ACTIVITY RELATION; SYNTHESIS; TRYPANOSOMA CRUZI;

ANIMALS; ANTIPROTOZOAL AGENTS; BENZAMIDINES; DRUG EVALUATION, PRECLINICAL; LEISHMANIA MEXICANA; MICE; MOLECULAR STRUCTURE; STRUCTURE-ACTIVITY RELATIONSHIP; TRYPANOCIDAL AGENTS; TRYPANOSOMA CRUZI;

EID: 0030633897     PISSN: 00262633     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. BARRAL A., Pedral-Sampaio D., Grimaldi Jr. G., Momen H., McMahon-Pratt D., Ribeiro de Jesus A., Almeida R., Badaró R., Barral-Neto M., Carvalho E. M., and Johnson Jr. W. D. 1991. Leishmaniasis in Bahia, Brazil. Evidence that Leishmania amazonensis produces a wide spectrum of clinical disease. Am. J. Trop. Med. Hyg. 44 535-546.
2. CROFT S. L. and Brazil R. P. 1982. Effect of pentamidine isethionate on the ultrastructure and morphology of Leishmania mexicana amazonensis in vitro. Ann. Trop. Med. Parasitol. 76 37-43.
3. HENDRICKS L D., Wood D. E. and Hajduk M. E. 1978. Haemoflagellates commercially available liquid media for rapid cultivation. Parasitol. 76 309-316.
4. JACKSON J. E., Tally J. D., Ellis W. Y., Mebrahtu Y. B., Lawyer R G., Were J. B., Reed S. G., Panisko D. M. and Limmer B. L 1990. Quantitative in vitro drug potency and drug susceptibility evaluation of Leishmania spp. from patients unresponsive to pentavalent antimony therapy. Am. J. Trop. Med. Hyg. 43 464-480.
5. LEON L. L., Machado G. M. C., Carvalho-Paes L. E. and Grimaldi Jr. G. 1990. Antigenic differences of Leishmania amazonensis isolates causing diffuse cutaneous leishmaniasis. Trans. R. Trop. Med. Hyg. 84 678-680.
6. LEON L L., Machado G. M. C., Barrai A., Carvalho-Paes L E. and Griamaldi Jr. G. 1992. Antigenic differences among Leishmania amazonensis isolates and their relationship with distinct clinical forms of the disease. Mem. Inst. Oswaldo Cruz. 87 229-234.
7. MESA-VALLE C. M., Craciunescu D., Parrondo-Iglesias E. and Osuna A. 1989. In vitro action of platinum (II) and platinum (IV) complexes on Trypanosoma cruzi and Leishmania donovani. Arzneim. Forsch./Drug Res. 39 838-42.
8. OLLIARO P .L. and Bryceson A. M. 1993. Practical progress and new drugs for changing patterns of leishmaniasis. Parasitol. Today 9 323-8.
9. SANTOS L. H. S. 1993. N-N'-difenilbenzamidinas: Síntese, Correlaçōes de Hammeff e Atividade Biologica. MSc thesis, LFRRJ.
10. SILVA L. H. P. and Nussenzweig V. 1953. Sobre uma cepa de Trypanosoma cruzi altamente virulenta para o camundongo branco. Folha clin. Biol. 20 191-207. In Portuguese.
11. VIANNA G. 1914. Sobre o tratamento de leishmaniose tegumentar. An. Paul. Med. Cirur. 2 167-9.